Search trials for
Showing NN of NN trials
Enrolling

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares i...

The purpose of this second extension study is to collect long-term safety and tolerability data and additional efficacy data in...

Not Yet Enrolling

The the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XNW3009 i...

XNW3009 is a small molecule hURAT1 inhibitor developed independently by Sinovent Pty Ltd., and is intended to treat gout-related hyperuricemia. ...

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates